Takeda Pharmaceutical (TAK) Inventory: 2018-2025

  • Takeda Pharmaceutical's Inventory fell 2.26% to $8.0 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $8.0 billion, marking a year-over-year decrease of 2.26%. This contributed to the annual value of $8.0 billion for FY2025, which is 4.74% down from last year.
  • Per Takeda Pharmaceutical's latest filing, its Inventory stood at $8.0 billion for Q1 2025, which was down 2.26% from $8.2 billion recorded in Q1 2024.
  • Takeda Pharmaceutical's 5-year Inventory high stood at $8.2 billion for Q1 2024, and its period low was $7.1 billion during Q1 2021.
  • Moreover, its 3-year median value for Inventory was $8.0 billion (2025), whereas its average is $7.9 billion.
  • Its Inventory has fluctuated over the past 5 years, first grew by 9.47% in 2024, then declined by 2.26% in 2025.
  • Over the past 5 years, Takeda Pharmaceutical's Inventory (Quarterly) stood at $7.1 billion in 2021, then increased by 3.08% to $7.3 billion in 2022, then grew by 1.58% to $7.5 billion in 2023, then increased by 9.47% to $8.2 billion in 2024, then declined by 2.26% to $8.0 billion in 2025.
  • Its Inventory was $8.0 billion in Q1 2025, compared to $8.2 billion in Q1 2024 and $7.5 billion in Q1 2023.